Keywords: threat, yamanouchi, pfizer, takes, over, warner-lambert, under

Threat to Yamanouchi if Pfizer takes over Warner-Lambert?

Article | 16 November 1999

Under Yamanouchi's contract with Warner-Lambert for the best-sellinglipid-lowering drug Lipitor (atorvastatin) in Japan, W-L has copromotion rights but will not ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Pfizer

Go to company listing

Related Drugs

atorvastatin

Lipitor

Go to drug listing